DD252614A5 - Verfahren zur Herstellung von Hepatitis B-Oberflächenantigenen - Google Patents
Verfahren zur Herstellung von Hepatitis B-Oberflächenantigenen Download PDFInfo
- Publication number
- DD252614A5 DD252614A5 DD29662586A DD29662586A DD252614A5 DD 252614 A5 DD252614 A5 DD 252614A5 DD 29662586 A DD29662586 A DD 29662586A DD 29662586 A DD29662586 A DD 29662586A DD 252614 A5 DD252614 A5 DD 252614A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- dna
- plasmid
- dna fragment
- fragment
- hepatitis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Beans For Foods Or Fodder (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/801,713 US4895800A (en) | 1985-11-26 | 1985-11-26 | Yeast production of hepatitis B surface antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
DD252614A5 true DD252614A5 (de) | 1987-12-23 |
Family
ID=25181867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD29662586A DD252614A5 (de) | 1985-11-26 | 1986-11-25 | Verfahren zur Herstellung von Hepatitis B-Oberflächenantigenen |
Country Status (28)
Country | Link |
---|---|
US (1) | US4895800A (sv) |
EP (1) | EP0226846B1 (sv) |
JP (1) | JPH0763372B2 (sv) |
KR (1) | KR920004050B1 (sv) |
CN (1) | CN86107885A (sv) |
AT (1) | ATE92527T1 (sv) |
AU (1) | AU583683B2 (sv) |
CA (1) | CA1285895C (sv) |
CS (1) | CS276453B6 (sv) |
DD (1) | DD252614A5 (sv) |
DE (1) | DE3688831T2 (sv) |
DK (1) | DK565186A (sv) |
EG (1) | EG17949A (sv) |
ES (1) | ES2058055T3 (sv) |
FI (1) | FI95929C (sv) |
HU (1) | HUT43112A (sv) |
IE (1) | IE64519B1 (sv) |
IL (1) | IL80754A (sv) |
IN (1) | IN166428B (sv) |
MX (1) | MX4334A (sv) |
NO (1) | NO176025C (sv) |
NZ (1) | NZ218286A (sv) |
PH (2) | PH25941A (sv) |
PL (1) | PL152882B1 (sv) |
PT (1) | PT83819B (sv) |
TW (1) | TW215457B (sv) |
YU (1) | YU46031B (sv) |
ZA (1) | ZA868601B (sv) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4777240A (en) * | 1984-03-08 | 1988-10-11 | Scripps Clinic And Research Foundation | SV40 expression vector containing HBxAg as an expression marker |
GB8521496D0 (en) * | 1985-08-29 | 1985-10-02 | Ciba Geigy Ag | Repressible yeast promoters |
US5032516A (en) * | 1985-10-25 | 1991-07-16 | Phillips Petroleum Company | Pichia pastoris alcohol oxidase II regulatory region |
US5135868A (en) * | 1985-10-25 | 1992-08-04 | Phillips Petroleum Company | Cultures of yeast of the genus Pichia altered by site selective genomic modification |
US4683293A (en) * | 1986-10-20 | 1987-07-28 | Phillips Petroleum Company | Purification of pichia produced lipophilic proteins |
US5026828A (en) * | 1987-02-27 | 1991-06-25 | Merck & Co., Inc. | Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast |
EP0280470B1 (en) * | 1987-02-27 | 1993-07-07 | Merck & Co. Inc. | Method of purifying recombinant pres-1/s-2/s hepatitis b antigen from yeast |
ATE93891T1 (de) * | 1987-03-09 | 1993-09-15 | Merck & Co Inc | Reinigung von rekombiniertem hepatitis-boberfl|chen-antigen. |
WO1988010300A1 (en) * | 1987-06-22 | 1988-12-29 | Medico Labs Ag | Heterologous viral peptide particle immunogens |
EP0314240A3 (en) * | 1987-10-26 | 1990-03-28 | Merck & Co. Inc. | Process for purifying recombinant hepatitis antigens |
US5011915A (en) * | 1987-10-26 | 1991-04-30 | Merck & Co., Inc. | Process for purifying recombinant hepatitis antigens |
US5004688A (en) * | 1988-04-15 | 1991-04-02 | Phillips Petroleum Company | Purification of hepatitis proteins |
IL89991A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of hepatitis b pres2 protein in methylotrophic yeasts |
IL89993A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of the hiv 24kda gag protein in methylotrophic yeasts |
IL89989A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of human interleukin-2 in methylotrophic yeasts |
IL89992A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of human serum albumin in methylotrophic yeasts |
IL90021A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Process for the production of interferon |
IL90161A0 (en) * | 1988-05-13 | 1989-12-15 | Phillips Petroleum Co | Expression of hepatitis b s and pres2 proteins in methylotrophic yeasts |
WO1990003431A1 (en) * | 1988-09-26 | 1990-04-05 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Mixed feed recombinant yeast fermentation |
WO1990009434A1 (en) * | 1989-02-13 | 1990-08-23 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of superoxide dismutase in pichia pastoris yeast cells |
US6197548B1 (en) | 1990-04-02 | 2001-03-06 | Medeva Pharma Limited | Transformed Pichia expressing the pertactin antigen |
WO1992004363A1 (en) * | 1990-09-04 | 1992-03-19 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of insulin-like growth factor-1 in methylotrophic yeast cells |
US5612198A (en) * | 1990-09-04 | 1997-03-18 | The Salk Institute | Production of insulin-like growth factor-1 in methylotrophic yeast cells |
CU22290A1 (es) * | 1990-10-08 | 1995-01-31 | Cigb | Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal |
US5268273A (en) * | 1990-12-14 | 1993-12-07 | Phillips Petroleum Company | Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same |
EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
WO1992013951A1 (en) * | 1991-02-04 | 1992-08-20 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Production of human serum albumin in methylotrophic yeast cells |
CA2063890C (en) * | 1991-03-27 | 2007-03-13 | Masami Miura | Mutant aox2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism |
JPH06506117A (ja) * | 1991-04-01 | 1994-07-14 | メルク エンド カンパニー インコーポレーテッド | ピキア(Pichia)蛋白質分解活性に影響する遺伝子およびその使用 |
CA2058820C (en) * | 1991-04-25 | 2003-07-15 | Kotikanyad Sreekrishna | Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells |
US5330901A (en) * | 1991-04-26 | 1994-07-19 | Research Corporation Technologies, Inc. | Expression of human serum albumin in Pichia pastoris |
US5850025A (en) * | 1991-09-19 | 1998-12-15 | Sibia Neurosciences, Inc. | Protection of plants against plant pathogens |
EP0642355B1 (en) | 1992-05-23 | 1998-07-15 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Combined vaccines comprising hepatitis b surface antigen and other antigens |
ES2108278T3 (es) | 1992-06-25 | 1997-12-16 | Smithkline Beecham Biolog | Composicion de vacuna con coadyuvantes. |
JPH06209763A (ja) * | 1993-01-13 | 1994-08-02 | Green Cross Corp:The | 変異株 |
CA2202351A1 (en) * | 1994-10-18 | 1996-04-25 | George Phillip Vlasuk | Nematode-extracted serine protease inhibitors and anticoagulant proteins |
US5945275A (en) * | 1994-10-18 | 1999-08-31 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5872098A (en) * | 1995-06-05 | 1999-02-16 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5866543A (en) * | 1995-06-05 | 1999-02-02 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5866542A (en) * | 1994-10-18 | 1999-02-02 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
DE69535317T2 (de) * | 1994-10-18 | 2007-06-21 | Dendreon Corp., Seattle | Aus nematoden extrahierte serinprotease-inhibitoren und die koagulation hemmende proteine |
US5863894A (en) * | 1995-06-05 | 1999-01-26 | Corvas International, Inc. | Nematode-extracted anticoagulant protein |
US5955349A (en) * | 1996-08-26 | 1999-09-21 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
US5716808A (en) * | 1995-11-09 | 1998-02-10 | Zymogenetics, Inc. | Genetic engineering of pichia methanolica |
GB9623233D0 (en) | 1996-11-07 | 1997-01-08 | Smithkline Beecham Biolog | Vaccine composition |
EP2266604A3 (en) | 1998-10-16 | 2011-05-11 | GlaxoSmithKline Biologicals S.A. | Adjuvant systems and vaccines |
UA79735C2 (uk) | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
ATE494367T1 (de) * | 2002-12-18 | 2011-01-15 | Hoffmann La Roche | Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität |
DE60319333D1 (de) * | 2002-12-20 | 2008-04-10 | Roche Diagnostics Gmbh | Hitzelabile Desoxyribonuklease I-Varianten |
EP1460425A1 (en) * | 2003-03-17 | 2004-09-22 | Boehringer Mannheim Gmbh | Deglycosylated enzymes for conjugates |
JP4411192B2 (ja) * | 2003-12-05 | 2010-02-10 | エフ.ホフマン−ラ ロシュ アーゲー | 組換えで発現されるカルボキシペプチダーゼbおよびその精製 |
PL1926749T3 (pl) * | 2005-09-14 | 2011-12-30 | Sanofi Aventis Deutschland | Cięcie prekursorów insuliny przez wariant trypsyny |
BRPI0708865A8 (pt) | 2006-03-14 | 2019-01-22 | Univ Oregon Health & Science | métodos para produzir uma resposta imune à tuberculose |
EP2066344B2 (en) | 2006-09-07 | 2016-06-29 | GlaxoSmithKline Biologicals S.A. | Inactivated Poliovirus combination vaccine |
JP4216875B2 (ja) * | 2006-09-29 | 2009-01-28 | 株式会社東芝 | メタノール応答性プロモーター、プロモーターと外来遺伝子を発現可能な様式で連結した融合遺伝子、ベクター、形質転換体、およびタンパク質の生産方法 |
AU2008221383B2 (en) | 2007-02-28 | 2012-09-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Brachyury polypeptides and methods for use |
UY31064A1 (es) | 2007-05-02 | 2009-01-05 | Glaxosmithkline Biolog Sa | Vacuna |
US9415006B2 (en) | 2008-05-23 | 2016-08-16 | The Regents Of The University Of Michigan | Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same |
US9005631B2 (en) | 2008-08-04 | 2015-04-14 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine |
WO2010099472A2 (en) | 2009-02-27 | 2010-09-02 | The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services | Spanx-b polypeptides and their use |
WO2011047340A1 (en) | 2009-10-16 | 2011-04-21 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine |
GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
WO2013152352A1 (en) | 2012-04-06 | 2013-10-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Live, attenuated rubella vector to express vaccine antigens |
ES2752190T3 (es) | 2012-09-14 | 2020-04-03 | Us Health | Proteína Brachyury, vectores adenovirales que codifican proteína Brachyury y su uso |
ES2597832T3 (es) | 2013-03-08 | 2017-01-23 | Janssen Vaccines & Prevention B.V. | Vacuna acelular contra la tosferina |
CA2994694A1 (en) | 2015-08-03 | 2017-02-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2480779B2 (fr) * | 1979-08-30 | 1986-07-18 | Anvar | Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur |
GB2055847A (en) * | 1979-07-30 | 1981-03-11 | Bull F G | Process for the production of carrier particles |
US4769238A (en) * | 1981-08-04 | 1988-09-06 | The Regents Of The University Of California | Synthesis of human virus antigens by yeast |
US4803164A (en) * | 1981-08-31 | 1989-02-07 | Genentech, Inc. | Preparation of hepatitis b surface antigen in yeast |
NZ201705A (en) * | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
DE3381619D1 (de) * | 1982-08-16 | 1990-07-05 | Chemo Sero Therapeut Res Inst | Pendelvektor. |
IL69202A (en) * | 1982-09-08 | 1991-08-16 | Smith Kline Rit | Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof |
US4510245A (en) * | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
CA1341116C (en) * | 1983-02-22 | 2000-10-17 | Rae Lyn Burke | Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein |
US4515714A (en) * | 1983-03-09 | 1985-05-07 | Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute | Method for purification of hepatitis B virus surface antigen |
KR850001534A (ko) * | 1983-08-22 | 1985-03-30 | 제임스 에프. 나우톤 | 형질전환된 효모로 부터 유도된 면역원성 HBsAg |
US4614793A (en) * | 1983-10-14 | 1986-09-30 | Merck & Co., Inc. | Hepatitis A--subunit antigen |
JPS60196185A (ja) * | 1984-03-19 | 1985-10-04 | Chemo Sero Therapeut Res Inst | 形質転換酵母の培養方法 |
US4855231A (en) * | 1984-10-30 | 1989-08-08 | Phillips Petroleum Company | Regulatory region for heterologous gene expression in yeast |
US4879231A (en) * | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
US4837148A (en) * | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4882279A (en) * | 1985-10-25 | 1989-11-21 | Phillips Petroleum Company | Site selective genomic modification of yeast of the genus pichia |
-
1985
- 1985-11-26 US US06/801,713 patent/US4895800A/en not_active Expired - Lifetime
-
1986
- 1986-07-10 CA CA000513467A patent/CA1285895C/en not_active Expired - Lifetime
- 1986-11-12 MX MX433486A patent/MX4334A/es unknown
- 1986-11-12 ZA ZA868601A patent/ZA868601B/xx unknown
- 1986-11-12 IN IN819/CAL/86A patent/IN166428B/en unknown
- 1986-11-13 NZ NZ218286A patent/NZ218286A/en unknown
- 1986-11-14 IE IE302186A patent/IE64519B1/en not_active IP Right Cessation
- 1986-11-19 AU AU65384/86A patent/AU583683B2/en not_active Expired
- 1986-11-24 CN CN198686107885A patent/CN86107885A/zh active Pending
- 1986-11-24 PH PH34520A patent/PH25941A/en unknown
- 1986-11-24 EG EG733/86A patent/EG17949A/xx active
- 1986-11-25 ES ES86116302T patent/ES2058055T3/es not_active Expired - Lifetime
- 1986-11-25 DE DE86116302T patent/DE3688831T2/de not_active Expired - Lifetime
- 1986-11-25 IL IL80754A patent/IL80754A/xx unknown
- 1986-11-25 NO NO864704A patent/NO176025C/no not_active IP Right Cessation
- 1986-11-25 DD DD29662586A patent/DD252614A5/de unknown
- 1986-11-25 YU YU201386A patent/YU46031B/sh unknown
- 1986-11-25 JP JP61280567A patent/JPH0763372B2/ja not_active Expired - Fee Related
- 1986-11-25 AT AT86116302T patent/ATE92527T1/de active
- 1986-11-25 FI FI864791A patent/FI95929C/sv not_active IP Right Cessation
- 1986-11-25 KR KR1019860010018A patent/KR920004050B1/ko not_active IP Right Cessation
- 1986-11-25 HU HU864873A patent/HUT43112A/hu unknown
- 1986-11-25 DK DK565186A patent/DK565186A/da not_active Application Discontinuation
- 1986-11-25 EP EP86116302A patent/EP0226846B1/en not_active Expired - Lifetime
- 1986-11-26 PT PT83819A patent/PT83819B/pt not_active IP Right Cessation
- 1986-11-26 CS CS868641A patent/CS276453B6/cs unknown
- 1986-11-26 PL PL1986262598A patent/PL152882B1/pl unknown
- 1986-12-01 TW TW075105699A patent/TW215457B/zh active
-
1987
- 1987-11-06 PH PH36040A patent/PH25539A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD252614A5 (de) | Verfahren zur Herstellung von Hepatitis B-Oberflächenantigenen | |
DE69031556T2 (de) | Antigene sowie Verfahren zu deren Herstellung | |
DE69228497T2 (de) | Expression von menschlichen Serum-Albuminen in Pichia Pastoris | |
DE3689411T2 (de) | Methode zur erhöten Expression von Polypeptiden in Hefe des Gattung Pichia. | |
DE3586889T2 (de) | Regulatorregion fuer die expression von heterologen genen in hefe. | |
DE69132812T2 (de) | Pichia pastoris Säure-Phosphatase-Gen | |
DE3789866T2 (de) | DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung. | |
DE69224768T2 (de) | Expression von menschlichen Serum-Albuminen in Pichia pastoris | |
DE68912777T2 (de) | Insulin-analoge. | |
DE3486206T2 (de) | Expressionssysteme für Hefe mit PyK-Promotoren enthaltenden Vektoren und Synthese von Fremdproteinen. | |
DE3280468T2 (de) | Synthese von menschlichen Virusantigenen durch Hefe. | |
DE68929115T2 (de) | Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe | |
DE68927921T2 (de) | Expression von Hepatitis B S und preS2 Proteinen in methylotrophen Hefen | |
DE68928380T2 (de) | Expression von menschlichen Serumalbumin in methylotrophischen Hefen | |
DD218118A5 (de) | Verfahren zur herstellung eines hefe- oder nichthefepolypeptids | |
DE3689899T2 (de) | Verfahren und hybridpromotor zur steuerung der exogenen gentranskription. | |
DE69226028T2 (de) | Mutanter AOX2 Promotor, Mikroorganismen es enthaltend, Verfahren zur Herstellung und Produktion von heterologem Protein, das solche Mikroorganismen benutz | |
DE69133525T2 (de) | Verfahren zur Herstellung von recombinantem Hepatitis B Oberflächenantigen mit erhöhter Immunogen-Kapazität und Verwendung in einer Impfstoffzubereitung | |
DE69034051T2 (de) | Stabil transformierte Hefezellen und ihre Verwendung zur Herstellung von Albumin | |
DE69321235T2 (de) | Promoter vom k. lactis pyruvat-decarboxylase gen und anwendung davon | |
DE3588117T2 (de) | Zubereitung für die Herstellung von Hepatitis B Virus-Oberflächenantigen und polymerisierten Humanserumalbuminrezeptor tragende Partikel enthaltenden Vakzinen, tierische Zellen für die Herstellung von diesen Partikeln und Verfahren für ihre Erhaltung | |
DD283836A5 (de) | Verfahren zur bildung von antigenen hbv-teilchen | |
DE3878410T2 (de) | Verfahren zur erhoehung von gen-expression. | |
DE3887425T2 (de) | BAR1-Sekretions-Signal-Sequenz. | |
DE69433222T2 (de) | Mutanter AOX2-Promotor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RPI | Change in the person, name or address of the patentee (searches according to art. 11 and 12 extension act) | ||
RPV | Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act) | ||
ASS | Change of applicant or owner |
Owner name: RESEARCH CORPORATION TECHNOLOGIES, INC Effective date: 19940503 |
|
IF04 | In force in the year 2004 |
Expiry date: 20061126 |